RSS feed

Publications (original articles or review articles) published in 2024 from OUS - Dept. of Gastroenterology (Div Medicine)

17 publications found

Andersen V, Pingel J, Søfelt HL, Hikmat Z, Johansson M, Pedersen VS, Bertelsen B, Carlsson A, Lindh M, Svavarsdóttir E, Repsilber D, Joergensen MT, Christensen R, Fejrskov A, Füchtbauer JD, Kjeldsen J, Jensen MD, Aalykke C, Rejler M, Høivik ML, Davidsdottir L, Carlson M, Halfvarson J, Zachariassen HH, Petersen LB et al. (2024)
Sex and gender in inflammatory bowel disease outcomes and research
Lancet Gastroenterol Hepatol, 9 (11), 1041-1051
DOI 10.1016/S2468-1253(24)00159-6, PubMed 39395438

Anisdahl K, Lirhus SS, Medhus AW, Moum B, Melberg HO, Høivik ML (2024)
Frailty risk and treatment strategy in elderly-onset inflammatory bowel disease. A Norwegian nationwide population-based registry study
Dig Liver Dis, 56 (9), 1503-1510
DOI 10.1016/j.dld.2024.02.002, PubMed 38433021

Dale HF, Hagen M, Malmstrøm GH, Fiennes JT, Høivik ML, Kristensen VA, Valeur J (2024)
Assessing hard and loose "endpoints": comparison of patient and expert Bristol Stool Scale scoring of 2280 fecal samples
F1000Res, 13, 833
DOI 10.12688/f1000research.152496.2, PubMed 39872194

Druckrey-Fiskaaen KT, Vold JH, Madebo T, Midgard H, Dalgard O, Leiva RA, Fadnes LT, INTRO-HCV Study Group (2024)
Liver stiffness and associated risk factors among people with a history of injecting drugs: a prospective cohort study
Subst Abuse Treat Prev Policy, 19 (1), 21
DOI 10.1186/s13011-024-00603-z, PubMed 38532435

Ecklu-Mensah G, Miller R, Maseng MG, Hawes V, Hinz D, Kim C, Gilbert JA (2024)
Modulating the human gut microbiome and health markers through kombucha consumption: a controlled clinical study
Sci Rep, 14 (1), 31647
DOI 10.1038/s41598-024-80281-w, PubMed 39738315

Holten KA, Bernklev T, Opheim R, Olsen BC, Detlie TE, Strande V, Ricanek P, Boyar R, Bengtson MB, Aabrekk TB, Asak Ø, Frigstad SO, Kristensen VA, Hagen M, Henriksen M, Huppertz-Hauss G, Høivik ML, Jelsness-Jørgensen LP (2024)
Fatigue in patients with inflammatory bowel disease in remission one year after diagnosis (the IBSEN III study)
J Crohns Colitis (in press)
DOI 10.1093/ecco-jcc/jjae170, PubMed 39527064

Lund C, Strande V, Hagen M, Bengtson MB, Boyar R, Detlie TE, Frigstad SO, Medhus AW, Henriksen M, Holten KIA, Hovde Ø, Huppertz-Hauss G, Johansen I, Olsen BC, Opheim R, Pallenschat J, Perminow G, Ricanek P, Torp R, Ystrøm CM, Høie O, Asak Ø, Vatn S, Aabrekk TB, Kristensen VA et al. (2024)
Low Surgery Rates in Early Crohn's Disease: Results from a Prospective Population-Based Inception Cohort-The Inflammatory Bowel Disease in South-Eastern Norway III Study
Inflamm Bowel Dis (in press)
DOI 10.1093/ibd/izae297, PubMed 39699202

Malme KB, Stene-Johansen K, Klundby I, Backe Ø, Foshaug T, Greve MH, Pihl CM, Finbråten AK, Dalgard O, Midgard H (2024)
Virologic Response and Reinfection Following HCV Treatment among Hospitalized People Who Inject Drugs: Follow-Up Data from the OPPORTUNI-C Trial
Viruses, 16 (6)
DOI 10.3390/v16060858, PubMed 38932151

Maurud S, Lunde L, Moen A, Opheim R (2024)
Exploring the foundations of a digital health information service for patients with inflammatory bowel disease: a mixed method study in Gravitate-Health
BMC Gastroenterol, 24 (1), 184
DOI 10.1186/s12876-024-03272-1, PubMed 38789953

Midgard H, Malme KB, Finbråten AK, Dalgard O (2024)
Treatment completion and SVR in the context of HCV elimination: Time to let go of the reins?
Clin Infect Dis (in press)
DOI 10.1093/cid/ciae298, PubMed 38824443

Midgard H, Malme KB, Pihl CM, Berg-Pedersen RM, Tanum L, Klundby I, Haug A, Tveter I, Bjørnestad R, Olsen IC, Finbråten AK, Dalgard O (2024)
Opportunistic Treatment of Hepatitis C Infection Among Hospitalized People Who Inject Drugs (OPPORTUNI-C): A Stepped Wedge Cluster Randomized Trial
Clin Infect Dis, 78 (3), 582-590
DOI 10.1093/cid/ciad711, PubMed 37992203

Oliver AJ, Huang N, Bartolome-Casado R, Li R, Koplev S, Nilsen HR, Moy M, Cakir B, Polanski K, Gudiño V, Melón-Ardanaz E, Sumanaweera D, Dimitrov D, Milchsack LM, FitzPatrick MEB, Provine NM, Boccacino JM, Dann E, Predeus AV, To K, Prete M, Chapman JA, Masi AC, Stephenson E, Engelbert J et al. (2024)
Single-cell integration reveals metaplasia in inflammatory gut diseases
Nature, 635 (8039), 699-707
DOI 10.1038/s41586-024-07571-1, PubMed 39567783

Salihovic S, Nyström N, Mathisen CB, Kruse R, Olbjørn C, Andersen S, Noble AJ, Dorn-Rasmussen M, Bazov I, Perminow G, Opheim R, Detlie TE, Huppertz-Hauss G, Hedin CRH, Carlson M, Öhman L, Magnusson MK, Keita ÅV, Söderholm JD, D'Amato M, Orešič M, Wewer V, Satsangi J, Lindqvist CM, Burisch J et al. (2024)
Identification and validation of a blood- based diagnostic lipidomic signature of pediatric inflammatory bowel disease
Nat Commun, 15 (1), 4567
DOI 10.1038/s41467-024-48763-7, PubMed 38830848

Strande V, Lund C, Hagen M, Bengtson MB, Cetinkaya RB, Detlie TE, Frigstad SO, Høie O, Medhus AW, Henriksen M, Aass Holten KI, Hovde Ø, Huppertz-Hauss G, Johansen I, Olsen BC, Opheim R, Ricanek P, Torp R, Tønnessen T, Vatn S, Aabrekk TB, Høivik ML, Kristensen VA (2024)
Clinical course of ulcerative colitis: Frequent use of biologics and low colectomy rate first year after diagnosis-results from the IBSEN III inception cohort
Aliment Pharmacol Ther, 60 (3), 357-368
DOI 10.1111/apt.18097, PubMed 38837289

Whittaker R, Midgard H, Dalgard O, Kløvstad H (2024)
Treatment uptake among notified cases of hepatitis C virus infection in Norway, 1990 to 2022: a registry-based study to monitor progress towards elimination
Euro Surveill, 29 (46)
DOI 10.2807/1560-7917.ES.2024.29.46.2400180, PubMed 39544147

Wiken TH, Høivik ML, Anisdahl K, Buer L, Warren DJ, Bolstad N, Hagen M, Moum BA, Medhus AW (2024)
Subcutaneous Vedolizumab Treatment in a Real-World Inflammatory Bowel Disease Cohort Switched From Intravenous Vedolizumab: Eighteen-Month Prospective Follow-up Study
Crohns Colitis 360, 6 (1), otae013
DOI 10.1093/crocol/otae013, PubMed 38544907

Zerouga I, Valeur J, Sommer C, Cvancarova Småstuen M, Medhus AW, Lund C, Johansen I, Cetinkaya RB, Bengtson MB, Torp R, Hovde Ø, Huppertz-Hauss G, Detlie TE, Aabrekk TB, Ricanek P, Frigstad SO, Hopstock LA, Opheim R, Kristensen VA, Høivik ML, Hauger Carlsen M, Aas AM (2024)
Dietary intake and nutritional status in patients with newly diagnosed inflammatory bowel disease: insights from the IBSEN III study
Scand J Gastroenterol, 59 (6), 652-660
DOI 10.1080/00365521.2024.2313056, PubMed 38356408